• 1
    Akao, Y., Tsujimoto, Y., Finnan, J., Nowell, P.C., Croce, C.M. (1990) Molecular characterization of a t(11;14)(q23;q32) chromosome translocation in a B-cell lymphoma. Cancer Research, 50, 4856 4859.
  • 2
    Chen, G.Q., Zha, J., Shi, X.G., Ni, J.H., Zhong, H.J., Si, G.Y., Jin, X.L., Tang, W., Li, X.S., Xong, S.M., Shen, Z.X., Sun, G.L., Ma, J., Zhang, P., Zhang, T.D., Gazin, C., Naoe, T., Chen, S.J., Wang, Z.Y., Chen, Z. (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα/PML protein . Blood, 88, 1052 1061.
  • 3
    Iida, S., Saito, M., Okazaki, T., Seto, M., Yamamoto, K., Akao, Y., Ogura, M., Suzuki, H., Ariyoshi, Y., Koike, K., Nitta, M., Takahashi, T., Ueda, R., Nakazawa, S. (1992) Phenotypic and genotypic characterization of 14 leukemia and lymphoma cell lines with 11q23 translocations. Leukemia Research, 12, 1155 1163.
  • 4
    Markwell, M.A.K., Hass, S.M., Tolbert, N.E., Bieber, L.L. (1981) Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods in Enzymology, 72, 296 303.
  • 5
    Miura, M., Zhu, H., Rotello, R., Hartwieg, E.A., Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75, 653 660.
  • 6
    Naoe, T., Akao, Y., Yamada, K., Utsumi, K.R., Koike, K., Shamoto, M., Koie, K., Kuramoto, Y., Kato, K., Abe, M., Shiku, H. (1988) Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukaemia cells. Cancer Genetics and Cytogenetics, 34, 77 88.
  • 7
    Palacios, R., Karasuyama, H., Rolink, A. (1987) Ly1+ pro-B lymphocyte clone, phenotype, growth requirements and differentiation in vitro and in vivo. EMBO Journal, 6, 3687 3693.
  • 8
    Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sun, G.L., Yang, K.Q., Chen, Y., Zhou, L., Fang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, Z., Wang, Z.Y. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients . Blood, 89, 3354 3360.
  • 9
    Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H., Tsujimoto, Y. (1996) Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene, 12, 2251 2257.
  • 10
    Webb, A., Cunningham, D., Cotter, F., Clarke, P.A., Di Stefano, F., Ross, P., Corbo, M., Dziewanowska, Z. (1997) BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet, 349, 1137 1141.
  • 11
    Yamamoto, K., Seto, M., Akao, Y., Iida, S., Nakazawa, S., Oshimura, M., Takahashi, T., Ueda, R. (1993) Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation. Oncogene, 8, 479 485.
  • 12
    Zhu, J., Koken, M.H.S., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., Chen, Z., De Thè, H. (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 94, 3978 3983.